ROTEM in patients with blood group O vs non-O
| . | Blood group O (n = 136) . | Blood group non-O (n = 150) . | P . | BHC . | P* . | BHC* . |
|---|---|---|---|---|---|---|
| Clotting time, mean (SD), s | 671.5 (126.1) | 637.4 (111.8) | .016 | <.05 | .492 | NS |
| Clot formation time, median (IQR), s | 177.0 (149.5-216.5) | 162.0(137.0-206.0) | .043 | NS | .777 | NS |
| Maximum clot firmness, mean (SD), mm | 56.7 (5.0) | 56.5 (5.6) | .799 | NS | .014 | <.05 |
| Maximal lysis, mean (SD), % | 13.3 (4.0) | 15.0 (4.5) | .001 | <.05 | .002 | <.05 |
| . | Blood group O (n = 136) . | Blood group non-O (n = 150) . | P . | BHC . | P* . | BHC* . |
|---|---|---|---|---|---|---|
| Clotting time, mean (SD), s | 671.5 (126.1) | 637.4 (111.8) | .016 | <.05 | .492 | NS |
| Clot formation time, median (IQR), s | 177.0 (149.5-216.5) | 162.0(137.0-206.0) | .043 | NS | .777 | NS |
| Maximum clot firmness, mean (SD), mm | 56.7 (5.0) | 56.5 (5.6) | .799 | NS | .014 | <.05 |
| Maximal lysis, mean (SD), % | 13.3 (4.0) | 15.0 (4.5) | .001 | <.05 | .002 | <.05 |
ANCOVA, adjusted for sex and VWF:Ag, VWF:RCo, and FVIII levels.